Top Markets
Coin of the day
Rafael Holdings, Inc. Rafael Holdings, Inc.

Rafael Holdings, Inc.

RFL
Rank in Stocks #21321
Rafael Holdings, Inc. holds strategic investments in both early-stage and... Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Share Price
$2.15
Last synced: 2026-08-21
Market Cap
$110.06M
Change (1 day)
13.46%
Change (1 year)
37.76%
Country
US
Trade Rafael Holdings, Inc. (RFL)

Category

Stock price history for Rafael Holdings, Inc. (RFL)
Highest end of day price: $1.99 on 2026-08-01

Lowest end of day price: $4.80 on 2018-03-01
Stock price history of Rafael Holdings, Inc. from 2018 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 18.63%
2025 -30.01%
2024 0.43%
2023 -1.66%
2022 -65.88%
2021 -76.43%
2020 22.88%
2019 122.13%
2018 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$152.07 -7.51%
US
$23.79 -29.07%
DE
$17.70 -4.51%
CN
$38.55 0.00%
DE
$387.58 27.83%
US